Summary Information:
Inhibikase Therapeutics Inc. Common Stock
NASDAQ:IKT
email
admin@troach.net 		Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net
NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.
Inhibikase Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: IKT
SEC CIK: 0001750149
Phone: 678-392-3419
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA GA 30339

CEO:
Price Quote by TradingView
Price when page updated: 0.853 Date: 2023-11-30
Company Website:
www.inhibikase.com

_Description: Inhibikase is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders that arise inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.

IPO YEAR:
2020
 Sector:
Health Care
 Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
5266661.00
 Beta:
1.419133192943167
52 Week High:
9.88
 52 Week Low:
1.52
 52 Week Change:
-0.8397959183673469
Short Interest:

Short Date:

Shares Outstanding:
25155198
Dividend Rate:
0
 Dividend Yield:
10.12%
ExDividend Date:

Latest EPS:

Latest EPS Date:
N/A
Float:
0
return on Equity:
-
 Consensus EPS:

Number Of Estimates:
EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
 Revenue:
N/A
 Gross Profit:
Cash:

Debt:

Institution Percent:
42.95%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
-
Return on Assets:
-
 Return on Capital:

Profit Margin:
-
Price to Sales:
-
 Price To Book:
-
 Short Ratio:
0.32
PE Ratio:
0
 Employees:
3
 1Y Guesstimate
N/A:N/A:N/A


__The following are links to various summary and news pages for
__Inhibikase Therapeutics Inc. Common Stock [ IKT ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX



Page design by: TRoach
Page Last Updated: 2023-11-30